Compare Extra Space Storage, Inc. (EXR) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Extra Space Storage, Inc. vs 10X Genomics Inc — how do they compare? Extra Space Storage, Inc. trades at $133.85 (market cap $28.12B), while 10X Genomics Inc trades at $81.44 (market cap $10.07B). The key difference: Extra Space Storage, Inc. is far larger — about 2.8× 10X Genomics Inc's market cap, and Extra Space Storage, Inc. pays a 4.87% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Extra Space Storage, Inc. for 108 Days and 10X Genomics Inc for 92 Days on average.
| EXR | TXG | |
|---|---|---|
Market Cap | $28.12B | $10.07B |
Volume | 2,595,579 | 5,657,286 |
Sector | Real Estate | Health |
52-Week High | $152.85 | $97.74 |
52-Week Low | $126.67 | $11.48 |
Typical Hold Time | 108 Days | 92 Days |
Enterprise Value | $41.84B | $9.59B |
Dividend Yield | 4.87% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EXR trades at $133.3, up 1.21% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected soon. Revenue grew to $3.38B in 2025, and net income margin improved to 27.79%. Analyst consensus is split evenly between Buy and Hold, with a $158.33 price target suggesting upside. Recent news highlights leadership transition and institutional buying interest.
Outlook is mixed: solid fundamentals and analyst targets support growth, but technical weakness and high valuation ratios pose risks. Investors should weigh steady cash flow and dividend yield against debt levels and market sentiment shifts ahead of earnings.
TXG trades at $76.10, down 5.65% on the day, reflecting a bearish technical trend. The company reported revenue of $642.82M for 2025 with a net loss of $43.54M, though it has consistently beaten quarterly EPS estimates. Recent news highlights strong demand for its Atera spatial biology platform and a patent victory. The stock faces resistance near $77 and support at $72.
The outlook is mixed; strong product demand and improving margins offer upside, but persistent losses and high valuation ratios pose risks. Analyst consensus is divided, with a $74.30 price target slightly below the current price, indicating cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
